Summary
Vivid and bizarre dreams, hallucinations, sleep disturbance and psychosis have all been described following treatment with β-Blockers. It has been suggested that these central nervous system (CNS) side-effects are related to the degree of lipophilicity of the β-blocker. A randomized double-blind crossover study was performed to compare the incidence of CNS side-effects with atenolol and metoprolol in hypertensive patients who had reported CNS side-effects with lipophilic β-Blockers. Eleven women and six men completed the study, in which a 30-item psychiatric questionnaire was used to detect changes in psychological status and possible CNS side-effects. Discontinuation of the original lipophilic β-blocker produced a significant improvement in quality of sleep, dreams, concentration, memory, energy, and anxiety. No significant CNS side-effects were reported with atenolol, but introduction of metoprolol caused a significant increase in the incidence of sleep disturbance (p<0.01) and restless nights (p<0.05), as well as failure to achieve satisfactory sexual intercourse (p<0.05). When compared with atenolol, metoprolol was associated with a significantly higher incidence of restless disturbed nights (p<0.05). Blood pressure control was identical for both β-Blockers. This study appears to confirm the association between CNS-related side-effects and the lipophilicity of β-Blockers.
Similar content being viewed by others
References
Betts TA, Alford C (1983) Beta-blocking drugs and sleep: a controlled trial. Drugs 25 (Suppl 2): 268–272
Cruickshank JM (1980) The clinical importance of cardiose-lectivity and lipophilicity in beta-blockers. Am Heart J 100: 160–178
Fleminger R (1978) Visual hallucinations and illusions with propranolol. Br Med J 1: 1182
Fraser HS, Carr AC (1976) Propranolol psychosis. Br J Psychiatry 129: 508–509
Lennard MS, Silas JH, Freestone S, Trevethick J (1982) Defective metabolism of metoprolol in poor hydroxylators of debrisoquine. Br J Clin Pharmacol 14: 301–303
Mattiasson I, Henningsen NC (1978) Side-effects during treatment with lipid-soluble beta-adrenergic-blocking substances. Abstract. Proceedings of VIII World Congress of Cardiology, Tokyo: 367
Neil-Dwyer G, Bartlett J, McAinsh J, Cruickshank JM (1981) Beta-adrenoceptor blockers and the blood-brain barrier. Br J Clin Pharmacol 11: 549–553
Simpson WT (1977) Nature and incidence of unwanted effects with atenolol. Postgrad Med J 53 (Suppl 3): 162–167
Westerlund A (1983) A comparison of the central nervous system side effects caused by lipophilic and hydrophilic beta-blockers. Drugs 25 (Suppl 2): 280–281
Woods PB, Robinson ML (1981) An investigation of the comparative liposolubilities of beta-adrenoceptor blocking agents. J Pharm Pharmacol 33: 172–173
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cove-Smith, J.R., Kirk, C.A. CNS-related side-effects with metoprolol and atenolol. Eur J Clin Pharmacol 28 (Suppl 1), 69–72 (1985). https://doi.org/10.1007/BF00543713
Issue Date:
DOI: https://doi.org/10.1007/BF00543713